Medesis Financial Statements From 2010 to 2025
| ALMDP Stock | EUR 0.35 0.01 2.94% |
Check Medesis Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medesis Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Medesis financial statements analysis is a perfect complement when working with Medesis Pharma Valuation or Volatility modules.
Medesis |
Medesis Pharma SA Company Price To Sales Analysis
Medesis Pharma's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Medesis Pharma Price To Sales | 189.31 X |
Most of Medesis Pharma's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medesis Pharma SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Medesis Pharma SA has a Price To Sales of 189 times. This is much higher than that of the Healthcare sector and 92.37% higher than that of the Biotechnology industry. The price to sales for all France stocks is notably lower than that of the firm.
Medesis Pharma SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medesis Pharma's current stock value. Our valuation model uses many indicators to compare Medesis Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medesis Pharma competition to find correlations between indicators driving Medesis Pharma's intrinsic value. More Info.Medesis Pharma SA is the top company in current valuation category among its peers. It also is number one stock in shares outstanding category among its peers creating about 0.51 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for Medesis Pharma SA is roughly 1.98 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medesis Pharma's earnings, one of the primary drivers of an investment's value.About Medesis Pharma Financial Statements
Medesis Pharma shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Medesis Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in Medesis Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Medesis Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Medesis Pharma SA, a clinical development stage biopharmaceutical company, engages in the development of orally administered molecule drug candidates to address unmet medical needs. The company was founded in 2003 and is based in Montpellier, France. MEDESIS PHARMA is traded on Paris Stock Exchange in France.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Medesis Stock Analysis
When running Medesis Pharma's price analysis, check to measure Medesis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medesis Pharma is operating at the current time. Most of Medesis Pharma's value examination focuses on studying past and present price action to predict the probability of Medesis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medesis Pharma's price. Additionally, you may evaluate how the addition of Medesis Pharma to your portfolios can decrease your overall portfolio volatility.